by 
The enteral nutrition market provides feeding to patients who cannot obtain nutrition orally. It plays a vital role in preventing malnutrition and supporting adequate nourishment among chronic disease patients. Enteral nutrition products include tube feeding formulas, tube feeding pumps and accessories. They offer nutrients optimized for patient requirements and are administered directly to the gastrointestinal tract via a tube. Their use helps prevent dehydration and complications of inadequate nutrition. The rising incidence of chronic diseases such as cancer, gastrointestinal disorders and neurological conditions has increased the demand for enteral nutrition support worldwide.
The global enteral nutrition market is estimated to be valued at US$ 3.1 Bn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the enteral nutrition market are Abbott, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., Curtis Health Caps SP.
The key opportunities in the market include rising demand in home care settings and untapped potential in developing regions. Increasing preference for home care is prompting players to offer products suitable for self- and family-administration of enteral therapy. Moreover, growing medical infrastructure and awareness in emerging nations will boost market expansion outside developed markets.
Rapid globalization of key market players through partnerships, acquisitions and expansions will further fuel the global growth of enteral nutrition industry over the forecast period.
Market drivers
The rising prevalence of chronic diseases is the key driver for the enteral nutrition market. Conditions like cancer, gastrointestinal disorders and neurological conditions often necessitate enteral tube feeding for adequate nutrition support. According to WHO, chronic diseases accounted for over 70% deaths worldwide in 2020. As disease incidence grows in tandem with the aging population globally, demand for associated enteral nutrition products and services will continue surging.
PEST Analysis
Political: Regulations on enteral nutrition formulas and standards set by governments agencies like FDA. Laws on medical nutrition reimbursement by insurance providers.
Economic: Spending on healthcare and nutrition. Trends in insurance coverage for therapeutic and clinical nutrition. Impact of economic cycles on discretionary medical spending.
Social: Aging population driving demand for products supporting elderly nutrition needs. Growing incidence of chronic diseases requiring nutritional support. Rising health awareness increasing demand for specialized nutrition.
Technological: Advancements in formulas for disease specific needs. Development of easy to administer and digest products. Connected devices for optimizing nutritional support.
North America is the largest geographical market for enteral nutrition, accounting for over 40% share in terms of value sales. This is attributed to factors like high healthcare spending per capita, widespread insurance coverage and advanced clinical practice in tube feeding. Europe is the second largest market followed by Asia Pacific.
The Asia Pacific region excluding Japan is projected to be the fastest growing market for enteral nutrition during the forecast period. This high growth can be attributed to growing population size, increasing life expectancy, rising incidence of chronic diseases necessitating nutritional therapies and expansion of healthcare infrastructure and reimbursement in emerging economies.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
